Immune System Diseases

905 trials 381 recruiting

Filter these 905 trials by phase, country and sponsor.

Open in Search →

Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infe… Pending

2024-518420-80-00 Primary infection prophylaxis for secondary immunodefic 5
A randomized controlled, two-arm (1:1 ratio) Phase IIa trial to assess the efficacy and safety of obinutuzumab in treating adults with de no… Pending

2025-520641-69-00 Kidney disease 4
ADfind Pending

2025-521833-97-00 Moderate-to-severe atopic dermatitis 6
EVALUATION OF UCPVAX VACCINE +/- PEMBROLIZUMAB COMBINED WITH STANDARD TREATMENT AS ADJUVANT THERAPY IN PATIENTS WITH UNMETHYLATED GLIOBLASTO… Pending

2024-514399-42-00 Glioblastoma 4
A Phase IIa Trial Evaluating the Efficacy of anti-CD19 Chimeric Antigen Receptor Engineered T-Cells in Patients With Systemic Sclerosis (SSc… Pending

2024-519511-33-00 Patients will be included with a stable but active dise 4
D. pteronyssinus and D. farinae allergen extracts. Study of the sensitivity and specificity of the prick test diagnostic preparation Pending

2025-522469-31-00 Allergy to Dermatophagoides pteronyssinus 5
A Randomized Double-Blind, Placebo Controlled Trial of Abatacept (CTLA4-Ig) in Giant Cell Arteritis (ABAGART) Pending

2024-515287-31-00 Giant Cell Arteritis 5
A study to assess the safety and efficacy of different doses of ELV001 to treat active rheumatoid arthritis in patients with an inadequate r… Pending

2025-524005-32-00 Rheumatoid arthritis 4
Long-term effect of Dupilumab on acetylsalicylic acid (ASA) intolerance and its mechanisms in patients with non-steroidal anti-inflammatory … Pending

2024-520082-31-01 non-steroidal anti-inflammatory drug-exacerbated respir 6
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of… Pending

2023-507521-41-01 rheumatoid arthritis 3
A study to investigate a potential effect of rilzabrutinib (SAR444671) on ethinylestradiol and levonorgestrel from combined oral contracepti… Pending

2026-525350-11-00 Immune Thrombocytopenia Purpura 3
Clinical trial with dasatinib for the prevention of CAR-T side effects in patients with relapsed or treatment-resistant multiple myeloma und… Pending

2023-507537-16-00 Chimeric antigen receptor T cell therapy-associated cyt 9
Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184 Pending

2026-525590-40-00 human immunodeficiency virus (HIV) 3
The effect of Janus Kinase inhibitors on the heart in Rheumatoid Arthritis Pending

2025-520710-58-00 Diagnosis of RA according to the ACR/EULAR 2010 criteri 6
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants with Moderate-to-Severe Atopic Dermatitis (ADAPTIVE) Pending

2024-520117-50-00 Atopic Dermatitis 4
A multicenter double-blind, randomized, placebo-controlled phase I/II study to determine the safety, tolerability, potential efficacy and do… Pending

2024-518501-17-00 Peanut allergy 7
A Phase 3 extension study to assess the long-term safety and efficacy of remibrutinib in adult participants with moderate to severe hidraden… Pending

2025-523259-72-00 Hidradenitis Suppurativa (HS) 5
Relative bioavailability and effect of food study with GLPG3667 in healthy subjects Pending

2026-525706-35-00 inflammatory and autoimmune diseases 3
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from birch pollen allergy Pending

2024-517520-19-00 Patients with moderate-to-severe allergic rhinitis / rh 10
Rituximab for Treatment of Checkpoint Inhibitor Induced Immune Related Adverse Events Pending

2026-525728-18-00 All CTCAE (v. 6.0) grade 2-4 immune-related adverse eve 3
An Open-Label, Phase 1b, Multiple Ascending Dose Study of OM336 in Participants with Active Sjogren’s Disease or Idiopathic Inflammatory Myo… Pending

2025-524100-29-00 Seropositive autoimmune disease: Sjogren’s disease or i 3
Use of pegfilgrastim in severe chronic neutropenia Pending

2024-519009-36-01 Severe chronic neutropenia (SCN) 4
Testing the safety and efficacy of combining biologic drugs in Rheumatoid and Psoriatic Arthritis Pending

2024-518011-19-01 Psoriatic Arthritis 4
Evaluation of Tildrakizumab in the Treatment of Ocular Sequelae in Lyell syndrome Pending

2025-522556-10-01 Ocular Sequelae in Lyell syndrome 4